Thomas J. Herzfeld Advisors’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-100
| Closed | -$15K | – | 359 |
|
|
2021
Q2 | $15K | Hold |
100
| – | – | 0.01% | 179 |
|
|
2021
Q1 | $16K | Hold |
100
| – | – | 0.01% | 179 |
|
|
2020
Q4 | $23K | Hold |
100
| – | – | 0.01% | 170 |
|
|
2020
Q3 | $22K | Hold |
100
| – | – | 0.01% | 119 |
|
|
2020
Q2 | $24K | Hold |
100
| – | – | 0.01% | 154 |
|
|
2020
Q1 | $29K | Hold |
100
| – | – | 0.02% | 138 |
|
|
2019
Q4 | $29K | Hold |
100
| – | – | 0.01% | 155 |
|
|
2019
Q3 | $14K | Hold |
100
| – | – | 0.01% | 183 |
|
|
2019
Q2 | $9K | Hold |
100
| – | – | ﹤0.01% | 225 |
|
|
2019
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 251 |
|
|
2018
Q4 | $14K | Hold |
100
| – | – | 0.01% | 216 |
|
|
2018
Q3 | $26K | Hold |
100
| – | – | 0.01% | 194 |
|
|
2018
Q2 | $25K | Hold |
100
| – | – | 0.01% | 207 |
|
|
2018
Q1 | $20K | Hold |
100
| – | – | 0.01% | 232 |
|
|
2017
Q4 | $14K | Sell |
100
-225
| -69% | -$31.5K | 0.01% | 239 |
|
|
2017
Q3 | $53K | Hold |
325
| – | – | 0.02% | 179 |
|
|
2017
Q2 | $44K | Hold |
325
| – | – | 0.02% | 183 |
|
|
2017
Q1 | $63K | Hold |
325
| – | – | 0.03% | 189 |
|
|
2016
Q4 | $46K | Hold |
325
| – | – | 0.02% | 205 |
|
|
2016
Q3 | $47K | Hold |
325
| – | – | 0.03% | 185 |
|
|
2016
Q2 | $33K | Hold |
325
| – | – | 0.02% | 235 |
|
|
2016
Q1 | $43K | Hold |
325
| – | – | 0.02% | 212 |
|
|
2015
Q4 | $65K | Hold |
325
| – | – | 0.03% | 190 |
|
|
2015
Q3 | $51K | Hold |
325
| – | – | 0.02% | 190 |
|
|
2015
Q2 | $132K | Hold |
325
| – | – | 0.06% | 144 |
|
|
2015
Q1 | $149K | Buy |
325
+234
| +257% | +$107K | 0.07% | 134 |
|
|
2014
Q4 | $51K | Hold |
91
| – | – | 0.03% | 176 |
|
|
2014
Q3 | $48K | Buy |
+91
| New | +$48K | 0.03% | 200 |
|